Lupin obtains FDA nod for generic AbilifyAripiprazole Tablets are indicated for the treatment of schizophrenia and the acute treatment of manic and mixed episodes associated with bipolar I disorder. AllianceRx Walgreens Pharmacy selected as exclusive distributor of VivjoaVivjoa is the first FDA-approved medication to reduce the incidence of recurrent vulvovaginal candidiasis in post-menopausal women. How collaboration and technology are improving health in communities Panelists at DSN’s Industry Issues Summit discussed advances and innovations in improving community health. Camber intros theophylline extended-release tablets Theophylline ER tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases. AAM: Avalere study shows PBMs continue to block patient access to biosimilars The analysis reiterates that biosimilar challenges are not limited to the Humira market. CSL Seqirus prepared to deliver 2024/25 U.S. season influenza vaccine portfolio The vaccine portfolio is based on the trivalent strains recommended by the FDA's Vaccines and Related Biological Products Advisory Committee. Knapp launches shuttle for freezer applications Knapp is releasing its OSR shuttle technology for cold chain applications and projects. Dr. Reddy’s intros Avastin biosimilar in the U.K. Versavo (bevacizumab) is indicated for the treatment of several types of cancers. Industry Issues Summit: How VillageMD is transforming health care A fireside chat at DSN’s Industry Issues Summit highlighted VillageMD’s focus on patient care. Endo confirms reorganization plans Endo anticipates completing financial restructuring as early as late April 2024. First Previous 54 55 56 57 58 Next Last